Table 1.

Clinical characterization and treatment of children with narcolepsy.

Number, gender	Age at first symptoms (years)	Age at Ds (years)/Ds delay (months)	Age at onset (years)				Nocturnal sleep disturbance	HLA test	Initial/posterior BMI	Treatment after Ds
Sleepiness	Cataplexy	Hallucinations	Sleep paralysis
1, F	7	9/24	7	11	17	–	No	DQB1⁎06:02/DRB⁎15	P90–95/P90–95	M
2, F	9	10/8	9	9	9	–	Yes	DQB1⁎06:02/DRB⁎15	P90–95/P95–97	M+V
3, M	8	8/4	8	8	–	9	Yes	DQB1⁎06:02/DRB⁎15	P90–95/P97	M+V
4, M	6	8/14	6	–	–	–	No	DQB1⁎06:02/DRB⁎15	P85–90/P75–85	M
5, M	10	11/9	10	11	–	–	Yes	DQB1⁎06:02/DRB⁎15	P95–97/P>97	M+V
6, F	6	9/24	6	–	9	–	Yes	DQB1⁎06:02/DRB⁎15	P75/P25–50	M
7, M	10	11/15	10	–	–	–	Yes	DQB1⁎06:02	P85–90/P75–85	M
8, M	7	9/24	7	9	–	–	Yes	DQB1⁎06:02/DRB⁎15	P75–85/P85	M+V
Total (median)	6–10 (8)	8–11 (9)/4–24(14)	6–10 (8)	8–11 (9)	9–17 (9)

Ds – diagnosis; BMI – Body Mass Index; M – Methylphenidate; V – Venlafaxine.